Suppr超能文献

21世纪特应性皮炎的局部治疗

Topical treatment for atopic dermatitis in the 21st century.

作者信息

Johnson Sandra Marchese, Kincannon Jay M, Dudney Danette L

机构信息

Central Arkansas Veterans Healthcare System, USA.

出版信息

J Ark Med Soc. 2004 Sep;101(3):86-90.

Abstract

Atopic Dermatitis (AD) is a common cutaneous inflammatory disease. Recent estimates of prevalence in United States school children range from 10-20%. Topical treatment of AD is unsatisfactory. Now two new topical agents, tacrolimus and pimecrolimus, are revolutionizing the treatment of AD. Here we review AD as well as these breakthrough therapies.

摘要

特应性皮炎(AD)是一种常见的皮肤炎症性疾病。最近对美国学龄儿童患病率的估计在10%至20%之间。AD的局部治疗并不理想。现在,两种新的局部用药,他克莫司和吡美莫司,正在彻底改变AD的治疗方法。在此,我们对AD以及这些突破性疗法进行综述。

相似文献

4
Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Clin Ther. 2006 Dec;28(12):1972-82. doi: 10.1016/j.clinthera.2006.12.014.
7
Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Am J Clin Dermatol. 2011 Feb 1;12(1):15-24. doi: 10.2165/11319300-000000000-00000.
9
Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
Skin Therapy Lett. 2002 Apr;7(4):1-3.
10
Pimecrolimus in dermatology: atopic dermatitis and beyond.
Int J Clin Pract. 2005 Aug;59(8):969-74. doi: 10.1111/j.1368-5031.2005.00587.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验